PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.

[1]  Han Liu,et al.  PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma , 2016, Tumor Biology.

[2]  Guiping Yu,et al.  Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis. , 2015, Journal of thoracic disease.

[3]  J. Li,et al.  Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation , 2014, Oncogene.

[4]  N. Zhong,et al.  Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells , 2014, Tumor Biology.

[5]  Yong Li,et al.  Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy , 2014, Cancer and Metastasis Reviews.

[6]  Yong Li,et al.  Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance , 2013, Cell Death and Disease.

[7]  Yanqiu Hu,et al.  PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis , 2013, Tumor Biology.

[8]  M. Groettrup,et al.  An Artificial PAP Gene Breaks Self-tolerance and Promotes Tumor Regression in the TRAMP Model for Prostate Carcinoma. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  B. Jia,et al.  Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer , 2012, Tumor Biology.

[10]  Maoyu Li,et al.  Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin , 2011, Journal of cellular biochemistry.

[11]  X. Yao,et al.  Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics , 2009, BJU international.

[12]  Todd M Morgan,et al.  Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway. , 2009, Current cancer drug targets.

[13]  M. Hiraoka,et al.  The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors* , 2009, Journal of Biological Chemistry.

[14]  A. Dicker,et al.  Hypoxia in prostate cancer: observation to intervention. , 2008, The Lancet. Oncology.

[15]  Pingfu Fu,et al.  Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion , 2007, International journal of cancer.

[16]  F. Lee,et al.  YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia , 2007, Oncogene.

[17]  Nan Li,et al.  hPEBP4 Resists TRAIL-induced Apoptosis of Human Prostate Cancer Cells by Activating Akt and Deactivating ERK1/2 Pathways* , 2007, Journal of Biological Chemistry.

[18]  J. Simons,et al.  Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.

[19]  Robert R. Klein,et al.  Expression of mTOR signaling pathway markers in prostate cancer progression , 2006, The Prostate.

[20]  N. Dhalla,et al.  Angiogenesis--a new target for future therapy. , 2006, Vascular pharmacology.

[21]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[22]  E. Hay,et al.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[23]  E. Keller,et al.  The role of Raf kinase inhibitor protein (RKIP) in health and disease. , 2004, Biochemical pharmacology.

[24]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[25]  P. Jollès,et al.  Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. , 1984, Biochimica et biophysica acta.

[26]  M. Benson,et al.  Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells , 2003, The Prostate.